Results 181 to 190 of about 206,512 (311)

Targeting Microglial CD49a Inhibits Neuroinflammation and Demonstrates Therapeutic Potential for Parkinson's Disease

open access: yesAdvanced Science, EarlyView.
This study shows that integrin receptor CD49a (Itga1 gene) is significantly upregulated in hyperactivated microglia and microglia‐specific knockdown of Itga1 rescues neuroinflammation and neurodegeneration in a chronic Parkinson's disease (PD) model by targeting PGAM5‐mediated mitochondrial dysfunction and NLRP3 activation. Targeted inhibition of CD49a
Huanpeng Lu   +6 more
wiley   +1 more source

Detection of the viable myocardium. A perfusion scintigraphic study, before and after coronary bypass surgery in myocardial infarction patients [PDF]

open access: diamond, 1999
Willliam A. Chalela   +5 more
openalex   +1 more source

Esketamine/Ketamine: Dual‐Action Mechanisms and Clinical Prospects beyond Anesthesia in Psychiatry, Immunology, and Oncology

open access: yesAdvanced Science, EarlyView.
Esketamine and ketamine are widely used for perioperative analgesia and anesthesia. Despite their established roles in analgesia, sedation, and anesthesia, as well as emerging antidepressant, anti‐tumor, and anti‐inflammatory effects, their clinical use is limited due to side effects and addiction potential.
Yinxin Wang   +7 more
wiley   +1 more source

A Rare Case of Left Ventricular Noncompaction Discovered During Severe Rhythm Disorder: About a Case Report. [PDF]

open access: yesClin Case Rep
Nacanabo MW   +6 more
europepmc   +1 more source

Status of F-18 fluorodeoxyglucose uptake in normal and hibernating myocardium after glucose and insulin loading

open access: diamond, 2017
İsmet Sarikaya   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy